WebWe offer the broadest range of quality plasma-derived and recombinant therapies in the industry. Rare & Serious Diseases. Influenza Vaccines & Antivenoms ... CSL Seqirus … WebBuy CSL Shares. CSL Ltd (CSL) is a leading biotechnology business based in Australia. It opened the day at AUDA$285.99 after a previous close of AUDA$285.5. During the day the price has varied from a low of AUDA$285.32 to a high of AUDA$288.36. The latest price was AUDA$288.3 (25 minute delay). CSL is listed on the Australian Securities ...
Share Purchase Plan – Documents and Shareholder Access …
WebCSL’s offer is a 40% premium to the undisturbed Vifor Pharma share price from the 60 days prior to December 1. Vifor Pharma’s share price had increased in the past two weeks as speculation about a takeover emerged. The Switzerland-based company largest shareholder Patinex AG, which owns 23.2% of the company, has agreed to the deal. WebApr 11, 2024 · Market Average Movement. 8.4%. 10% most volatile stocks in AU Market. 14.9%. 10% least volatile stocks in AU Market. 3.5%. Stable Share Price: CSL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 2% a week. Volatility Over Time: CSL's weekly volatility (2%) has been stable over the past year. green yellow red light
CSL puts $16.4b bet on ageing, obesity - Australian Financial Review
WebDec 21, 2024 · 1 NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES 21 December 2024 SHARE PURCHASE PLAN – LETTER TO ELIGIBLE … WebDec 21, 2024 · At the time of writing, the CSL share price is $281.43, 2.8% higher than its previous close. For context, the S&P/ASX 200 Index (ASX: XJO) is also up today, having gained 0.35%.. Without further ... WebFeb 14, 2024 · CSL Limited (ASX:CSL) has wrapped up a share purchase plan (SPP) worth AU$750 million, which received strong support from eligible shareholders. The … fob breaking news